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Background
Rapid drug desensitization (DST) protocols have been
developed based on clinical evidence, but in vitro studies
are lacking. Understanding the mechanisms involved in
the early stages of DST will allow improvements in
patients’ treatment, overcome unwanted adverse reactions,
and identify markers for therapeutic efficacy. The aim of
this study is to demonstrate and characterize the induction
of hyporesponsiveness in murine mast cells by desensitiza-
tion and activation, phenotyping the cell surface.
Method
Mouse bone marrow derived mast cells (BMMCs) sensi-
tized with DNP (2,4-dinitrophenol)-IgE were activated or
desensitzed to DNP (1 ng). Desensitization was acheived
by sequential doubling doses of DNP every 10 min starting
at 1pg. After activation or desensitization, BMMCs were
rechallenged by an activating dose of DNP to assess
hyporesponsiveness. LAMP1 surface expression and
©¬-hexosaminidase (¥â-Hex) release were used as main
outcomes.
Results
DST inhibited the IgE-mediated degranulation of BMMCs
as desensitized cells released 43.3% less ¥â-Hex and
showed 73.2% lower LAMP1 surface expression compared
to activated BMMCs. A group of desensitized and acti-
vated BMMCs were challenged again with an extra dose
of 1 ng DNP-HAS and additional release of ¥â-Hex and
LAMP1 expresssion were not different from the negative
control, regardless whether BMMCs had been previously
desensitized or activated. The hyporesponsiveness state of
BMMCs induced by DST and activation was not due to
mediator depletion as calcium ionophore induced marked
release of ¥â-Hex in these cells. Expression of Fc¥åRI,
PDL1 and GP49 was assessed next. Activated and desensi-
tized BMMCs, respectively, expressed 40.3% and 15.7%
less Fc¥åRI, 45.9% and 13.1% less PDL1, and 23.5% and
11.3% less GP49 than negative controls. We observed that
while the expression of PDL1 on the cell membrane
decreased, its intracellular amount increased.
Conclusion
Rapid desensitization and activation induced hyporespon-
siveness in murine mast cells, which can be assessed by
LAMP1 expression and ¥â-Hex secretion. Hyporespon-
siveness is not due to depletion of mediators or mediated
by a soluble factors, and is associated with cell-surface
phenotype changes.
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